# A Relative Bioavailability and Food-Effect Study of GSK3640254 Tablet and Capsule Formulations in Healthy Participants

> **NCT04263142** · PHASE1 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 39 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** GSK3640254 Tablet
- **DRUG:** GSK3640254 Capsule

## Key facts

- **NCT ID:** NCT04263142
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-27
- **Primary completion:** 2020-03-24
- **Final completion:** 2020-03-24
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2021-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04263142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04263142, "A Relative Bioavailability and Food-Effect Study of GSK3640254 Tablet and Capsule Formulations in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04263142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*